Molecule Details
| InChIKey | QEMCDXCXSVPAAB-UHFFFAOYSA-N |
|---|---|
| Compound Name | 1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone |
| Canonical SMILES | O=c1c(C2=Nc3ccccc3S(=O)(=O)N2)c(O)c2cc(F)ccc2n1CCC1CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.99 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB08278 |
|---|---|
| Drug Name | 1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone |
| CAS Number | 477931-14-9 |
| Groups | experimental |
| ATC Codes | nan |
| Description | nan |
Categories: Heterocyclic Compounds, Fused-Ring Quinolines RNA Replicase, antagonists & inhibitors RNA-Dependent RNA Polymerase, antagonists & inhibitors Sulfur Compounds Thiazines
Cross-references: BindingDB: 50181559 CHEMBL372357 ChemSpider: 20114428 PDB: NN2 PubChem:5273394 PubChem:99444749 ZINC: ZINC000100036569
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P26663 | Genome polyprotein | binder | targets |